<DOC>
	<DOCNO>NCT00313794</DOCNO>
	<brief_summary>This study patient metastatic adenocarcinoma arise colon rectum receive treatment ( ) metastatic disease subsequent disease progression . Patients intolerant treatment ( ) also include . This study good performance status colorectal cancer patient exhaust standard therapy option .</brief_summary>
	<brief_title>Study Ticilimumab Patients With Metastatic Colorectal Cancer Whose Disease Had Progressed After Treatment</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Tremelimumab</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Radiographic evidence metastatic , progressive disease follow standard therapy . Eastern Cooperative Oncology Group ( ECOG ) performance status 01 . Known brain metastasis uncontrolled pleural effusion . History chronic inflammatory autoimmune disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>